The IL-2 receptor is involved in many aspects of immune function, including proliferation, lymphoid development, and peripheral tolerance. The receptor complex consists of a high affinity binding chain termed alpha, and beta and gammac subunits that mediate signal transduction. Downstream of this complex lie protein kinases, lipid kinases, adaptor molecules, and transcription factors. The precise relationship between the biochemical pathways and lymphocyte responses is still unclear. This research project proposes to elucidate the pathways by which IL-2 regulates T cell proliferation, using the murine T cell line CTLL2 as a model system. Current studies have shown that the proliferative response is regulated by at least two pathways, one involving the molecule Shc and the other potentially involving the transcription factor STAT5. Both these pathways can contribute somewhat to the expression of several pro-mitotic genes, including c-myc, bcl-x, and cyclin D2. The mechanism by which Shc contributes to the T cell proliferative response will be investigated. In addition, the role of MAP kinase and PI3 kinase pathways that lie downstream of Shc will be examined. Novel components of the Shc pathway may be isolated using the yeast-two hybrid strategy. The role of STAT5 in regulating T cell proliferation will be tested using dominant inhibitory forms of STAT5. Finally, IL-2-regulated transcription factors that modulate expression of cyclin D2 will be identified using a cyclin D2-luciferase construct. These studies should establish connections between IL-2 signaling and the control of cell cycle and will further understanding of the molecular regulation of T cell expansion during normal and pathological processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM057931-04
Application #
6519906
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Marino, Pamela
Project Start
1999-04-01
Project End
2004-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
4
Fiscal Year
2002
Total Cost
$384,630
Indirect Cost
Name
Benaroya Research Institute at Virginia Mason
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98101
Lockyer, Heather M; Tran, Eric; Nelson, Brad H (2007) STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. J Immunol 179:5301-8
Moon, James J; Rubio, Eric D; Martino, Anthony et al. (2004) A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J Biol Chem 279:5520-7
Nelson, Brad H; Martyak, Timothy P; Thompson, Lucas J et al. (2003) Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J Immunol 170:5563-70
Nelson, Brad H (2002) Interleukin-2 signaling and the maintenance of self-tolerance. Curr Dir Autoimmun 5:92-112
Martino, A; Holmes 4th, J H; Lord, J D et al. (2001) Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J Immunol 166:1723-9
Moon, J J; Nelson, B H (2001) Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor. J Immunol 167:2714-23
Lord, J D; McIntosh, B C; Greenberg, P D et al. (2000) The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol 164:2533-41
Gu, H; Maeda, H; Moon, J J et al. (2000) New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol Cell Biol 20:7109-20
Van Parijs, L; Refaeli, Y; Lord, J D et al. (1999) Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11:281-8